BIOMAT Database Logo BIOMAT Database Logo

Synthesis and absolute configuration of the optically active forms of 2-(bis(2-chloroethyl)amino)-4-methyltetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide (4-methylcyclophosphamide). 1977

R Kinas, and K Pankiewicz, and W J Stec

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009904 Optical Rotation The rotation of linearly polarized light as it passes through various media. Optical Activity,Activity, Optical,Rotation, Optical
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

R Kinas, and K Pankiewicz, and W J Stec
[Hypothetical metabolites of 2-bis(2-chloroethyl)amino-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide)].
March 1970, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
R Kinas, and K Pankiewicz, and W J Stec
[Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)].
August 1974, Arzneimittel-Forschung,
R Kinas, and K Pankiewicz, and W J Stec
[Competitive inhibition of the metabolism of 2(bis-(2-chlorethyl)-amino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide by phenylbutazone and phenobarbital in the rat].
December 1970, Arzneimittel-Forschung,
R Kinas, and K Pankiewicz, and W J Stec
Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
May 1973, Cancer research,
R Kinas, and K Pankiewicz, and W J Stec
[Arylaminotetrahydro-2H-1,3,2-oxazaphosphorine 2-oxides, analogues of cyclophosphamide (author's transl)].
May 1977, Archiv der Pharmazie,
R Kinas, and K Pankiewicz, and W J Stec
Synthesis, absolute configuration and conformation of optically active 1,2-homoheptafulvalene.
February 2003, Organic & biomolecular chemistry,
R Kinas, and K Pankiewicz, and W J Stec
Conformational Study of Some Saturated 2-[Bis(2-chloroethyl)amino]-1,3,2-benzoxazaphosphorinane 2-Oxides.
February 1998, The Journal of organic chemistry,
R Kinas, and K Pankiewicz, and W J Stec
THE ABSOLUTE CONFIGURATION OF OPTICALLY ACTIVE ISOVALINE.
December 1964, Chemical & pharmaceutical bulletin,
R Kinas, and K Pankiewicz, and W J Stec
Synthesis of C-18 Cecropia juvenile hormone to obtain optically active forms of known absolute configuration.
July 1971, Journal of the American Chemical Society,
R Kinas, and K Pankiewicz, and W J Stec
Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
October 1980, Journal of pharmaceutical sciences,
Copied contents to your clipboard!